A method of prevention or treatment of bowel dysfunction induced by oxycodone which comprises administering buprenorphine combined with oxycodone hydrochloride； pharmaceutical dosage Unit； kit that includes a Unit dose of buprenorphine and another of oxycodone hydrochloride； sistem A transdermal buprenorphine.

• 收藏
• 分享

专利权人:

PURDUE PHARMA L.P.

发明人:

HUMMEL MICHELE,KYLE DONALD J.,LAUTERMILCH NATHAN,WHITESIDE GARTH

申请号：

CL2014002790

公开号：

CL2014002790A1

申请日:

2014.10.16

申请国别(地区):

CL

年份:

2015

代理人:

摘要：

Disclosed in certain embodiments is a method of treating or preventing an opioid-induced adverse pharmacodynamic response comprising administering to a patient in need thereof an effective amount of buprenorphine.<；p>；USO DE BUPRENORFINA, SUS SALES, SOLVATOS Y MEZCLAS DE LOS MISMOS PARA PREPARAR UN MEDICAMENTO PARA LA PREVENCIÓ；N O TRATAMIENTO DE LA DISFUNCIÓ；N INTESTINAL INDUCIDA POR OXICODONA Y SU SAL CLORHIDRATO.<；/p>；

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/